文献速递关节外科创伤骨科

两阶段置换关节成形术治疗假体周围关节感染:第一阶段后脱落的发生率和原因

Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection: The Rate and Reason for the Attrition After the First Stage.
PubMed 文献 · J Arthroplasty · 2019-06-15

本研究回顾性分析本机构假体周围关节感染数据库中616例(237髋、379膝)拟行两阶段置换的患者,其中111例(18%)在至少1年随访内未接受再植入。未再植入原因包括保留间隔器状态良好不愿手术29例(26.1%)、补救手术23例(20.7%)、医学上不适合再植入59例(53.2%),其中34例在初始间隔器置入后1年内死亡。将未再植入的治疗失败纳入考虑后,两阶段置换队列2年总体成功率为65.7%。

要点

  • 约五分之一(18%)拟行两阶段置换的患者最终未接受再植入。
  • 未再植入者中53.2%因医学上不适合,其中34例在1年内死亡。
  • 考虑脱落组后,两阶段置换2年总体成功率为65.7%。

核心结论

  • 近五分之一的患者可能永远不会接受预期的再植入。
  • 在众多脱落原因中,死亡似乎是相对常见的事件。
  • 当前的治疗成功定义未考虑脱落组,因而夸大了两阶段置换关节成形术的相对成功率。

研究设计与样本

  • 回顾性审查本机构假体周围关节感染数据库,纳入616例(237髋、379膝)拟行两阶段置换的患者。
  • 其中111例(18%)在至少1年随访内未接受再植入。
  • 通过病历回顾和针对性访谈阐明脱落原因。

主要发现

  • 111例未再植入患者中,29例(26.1%)保留间隔器状态良好且不愿继续再植入。
  • 23例(20.7%)接受了补救手术。
  • 59例(53.2%)被认为医学上不适合再植入,其中34例在初始间隔器置入后1年内死亡。
  • 将未再植入的治疗失败纳入考虑后,两阶段置换队列2年总体成功率为65.7%。
  • 多变量回归模型识别出多个与未再植入治疗失败风险增加相关的因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two-stage exchange arthroplasty remains a popular surgical treatment for patients with chronic periprosthetic joint infection (PJI). Patients who do not receive reimplantation were largely overlooked in the current literature. We aimed at investigating the clinical outcomes of these patients. METHODS: Our institutional PJI database was retrospectively reviewed to identify 616 patients (237 hips, 379 knees) who were treated with an intended 2-stage exchange. Of them, 111 (18%) did not receive reimplantation within a minimum follow-up of 1 year. Chart review and targeted interviews were performed to elucidate the cause of attrition. Patients were considered to have failed treatment in the absence of reimplantation if they remained medically unfit for reimplantation, underwent a salvage procedure, or died during the study period. RESULTS: Of the 111 patients without reimplantation, 29 (26.1%) did well with their retained spacer and were unwilling to proceed with reimplantation, 23 (20.7%) underwent salvage procedures, and the remaining 59 (53.2%) were considered medically unfit for reimplantation, with 34 of them dying within 1 year of initial spacer insertion. The overall success rate for 2-stage exchange cohort at 2 years was 65.7% when treatment failure without reimplantation was taken into account. Several factors associated with increased risk of treatment failure without reimplantation were identified using a multivariate regression model. CONCLUSION: Almost 1 in 5 patients may never receive the intended reimplantation. Among many reasons for attrition, mortality appears to be a relatively common event. The current definition of treatment success does not take into account the attrition group and thus inflates the relative success of 2-stage exchange arthroplasty.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Wang Q, Goswami K, Kuo FC, et al. Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection: The Rate and Reason for the Attrition After the First Stage. J Arthroplasty. 2019. PMID: 31285090. doi:10.1016/j.arth.2019.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。